Login / Signup

Enzyme/pH dual stimuli-responsive nanoplatform co-deliver disulfiram and doxorubicin for effective treatment of breast cancer lung metastasis.

Peifu XiaoXiaoguang TaoHanxun WangHongbing LiuYupeng FengYueqi ZhuZhengzhen JiangTian YinYu ZhangHaibing HeJingxin GouXing Tang
Published in: Expert opinion on drug delivery (2023)
DSF-DOX NPs with controllable tumor-site delivery of DOX and DSF was a prospectively potential strategy for metastatic breast cancer treatment.
Keyphrases
  • cancer therapy
  • drug delivery
  • squamous cell carcinoma
  • small cell lung cancer
  • photodynamic therapy
  • drug release
  • replacement therapy